AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

NeurologyLive™ Adds Jefferson Headache Center to Its Strategic Alliance Partnership Program

November 14, 2019

CRANBURY, N.J.--(BUSINESS WIRE)--Nov 14, 2019--

NeurologyLive™, a multimedia platform dedicated to providing health care professionals treating neurological diseases with direct access to expert-driven, practice-changing news and insights in neurology, welcomes the Jefferson Headache Center to its Strategic Alliance Partnership (SAP) program.

“We are so excited to announce our partnership with the Jefferson Headache Center,” said Michael J. Hennessy Jr., president of MJH Life Sciences™, parent company of NeurologyLive®. “The center is an industry leader in research, treatment, and education, and we look forward working to together to improve patient care for headache and migraine disorders.”

Founded in 1982, the Jefferson Headache Center is one of the few academic centers in the country that specializes in the treatment of patients with all types of headache pain. In addition to treating patients, the Jefferson Headache Center is a teaching facility that gives fellows, residents, and medical students the highest quality of preparation, so that they can contribute to patient care and advance the level of knowledge of headache medicine. The center is also deeply invested in clinical research related to headache and migraine disorders.

The SAP program is designed to facilitate an open exchange of information among trusted peers, with the goal of improving patient care. Through this partnership, the Jefferson Headache Center will be able to share valuable content through NeurologyLive™, where readers have access to unprecedented content including clinical research, interviews and articles.

For more information about the NeurologyLive™ SAP program, click here.

For more information about the Jefferson Headache Center, please click here.

About NeurologyLive

A multimedia platform for health care professionals treating neurological diseases, NeurologyLive ™ delivers direct access to practice-changing news and expert insights directly from top medical conferences and researchers to improve the lives of patients with neurological diseases such as dementia and Alzheimer disease, epilepsy, headache and migraine, movement disorders, multiple sclerosis, neuromuscular diseases, sleep disorders and stroke. The NeurologyLive ™ platform offers an in-depth look at the hundreds of new treatments in development with ever-expanding mechanisms of action, all during an unprecedented time of growing demand for neurology expertise. The NeurologyLive ™ platform also connects visitors with the most up-to-date clinical trial results, Food and Drug Administration approvals, practice-changing research and expert insights. NeurologyLive ™ is a brand of MJH Life Sciences ™, the largest privately held, independent, full-service medical media company in the North America dedicated to delivering trusted health care news across multiple channels.

About Jefferson Headache Center

The Jefferson Headache Center is one of few academic headache centers in the country. Founded in 1982, the Center specializes in the treatment of patients with all types of headache and migraine disorders, taking on a holistic approach to patient care. Care teams consist of a multitude of providers, including neurologists, physiatrists, psychologists, psychiatrists, nurse practitioners, physician assistants, and nurses.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191114005475/en/

CONTACT: NeurologyLive™ Media Contacts

Alexandra Ventura, 609-716-7777, ext. 121

aventura@mjhassoc.com

John Patricolo, 609-325-4630

jpatricolo@mjhassoc.com

KEYWORD: NEW JERSEY UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: ONCOLOGY MENTAL HEALTH HEALTH OTHER HEALTH RESEARCH SCIENCE

SOURCE: NeurologyLive

Copyright Business Wire 2019.

PUB: 11/14/2019 09:09 AM/DISC: 11/14/2019 09:08 AM

http://www.businesswire.com/news/home/20191114005475/en